Aduro Biotech Awarded East Bay Innovation Award for its

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
122
Aduro Biotech Awarded East Bay Innovation Award for its Contributions in Life Sciences and the San Francisco East Bay Community

BERKELEY, Calif., March 10, 2017 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (Nasdaq: ADRO ), a biopharmaceutical company with three distinct immunotherapy technologies, announced today the receipt of the East Bay Economic Development Alliance’s (East Bay EDA) East Bay Innovation Award for its innovation within the life science industry and unique contributions to the East Bay’s prosperity and culture of innovation. 

“We are honored to have been recognized by the East Bay EDA for our innovative approach to the treatment of cancer and for our efforts to support and nurture the continued prosperity and rich culture that makes the East Bay what it is today,” stated Stephen Isaacs, chairman, president and chief executive officer of Aduro. “It is the diversity of our community—the people, the academic institutions, and businesses—that support us in our mission to bring innovative new therapies to individuals battling cancer.  We are grateful to be in the position to make a positive difference in the lives of others, within the East Bay and beyond.”

Founded in Berkeley in 2008 and housed in an 110,853-square foot building with state-of-the art research facilities, Aduro is proud to support the local community in a variety of ways.  The company seeks to spark a lasting interest in science through its participation with the Institute for Science, Technology, Engineering, and Mathematics (STEM) Education program at California University, East Bay, as well as help create industry awareness and employment opportunities in under-represented communities through an internship program conducted in partnership with local community colleges.  Additionally, the company maintains a close relationship with local academic institutions, including the University of California at Berkeley through a research collaboration relating to their Immunotherapeutics and Vaccine Research Initiative (IVRI), an initiative focused on identifying and advancing new treatment options and preventive modalities for cancer, infectious disease and autoimmune disease. 

A corporate video about Aduro is available at http://www.aduro.com/media/corporate-video/ .

About the East Bay Economic Development Alliance (East Bay EDA) The East Bay Economic Development Alliance is a public-private partnership founded in 1990, and serves the Bay Area’s East Bay region (Alameda and Contra Costa Counties). East Bay EDA’s mission is to be the regional voice and networking resource for strengthening the economy, building the workforce and enhancing the quality of life in the East Bay.  For more information on East Bay EDA, please go to: www.EastBayEDA.org

About Aduro Aduro Biotech, Inc. is an immunotherapy company focused on the discovery, development and commercialization of therapies that transform the treatment of challenging diseases. Aduro's technology platforms, which are designed to harness the body's natural immune system, are being investigated in cancer indications and have the potential to expand into autoimmune and infectious diseases. Aduro's LADD technology platform is based on proprietary attenuated strains of Listeria that have been engineered to express tumor-associated antigens to induce specific and targeted immune responses. This platform is being developed as a treatment for multiple indications, including mesothelioma, ovarian, lung and prostate cancers. Additionally, a personalized form of LADD, or pLADD, is being developed utilizing tumor neoantigens that are specific to an individual patient’s tumor. Aduro's STING Pathway Activator platform is designed to activate the STING receptor in immune cells, resulting in a potent tumor-specific immune response. ADU-S100 is the first STING Pathway Activator compound to enter the clinic and is currently being evaluated in a Phase 1 study in patients with cutaneously accessible metastatic solid tumors or lymphomas. Aduro’s B-select monoclonal antibody platform includes a number of immune modulating assets in research and preclinical development. Aduro is collaborating with leading global pharmaceutical companies to expand its products and technology platforms. For more information, please visit www.aduro.com .

Cautionary Note on Forward-Looking Statements

This press release contains forward-looking statements for purposes of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements regarding our intentions or current expectations concerning, among other things, our technology platforms, plans, and the potential for eventual regulatory approval of our product candidates. In some cases, you can identify these statements by forward-looking words such as “may,” “will,” “continue,” “anticipate,” “intend,” “could,” “project,” “seek,” “potential,” “expect” or the negative or plural of these words or similar expressions.  Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties that could cause actual results and events to differ materially from those anticipated, including, but not limited to, our history of net operating losses and uncertainty regarding our ability to achieve profitability, our ability to develop and commercialize our product candidates, our ability to use and expand our technology platforms to build a pipeline of product candidates, our ability to obtain and maintain regulatory approval of our product candidates, our ability to operate in a competitive industry and compete successfully against competitors that have greater resources than we do, our reliance on third parties, and our ability to obtain and adequately protect intellectual property rights for our product candidates.  We discuss many of these risks in greater detail under the heading “Risk Factors” contained in our annual report on Form 10-K for the year ended December 31, 2016, which is on file with the Securities and Exchange Commission. Any forward-looking statements that we make in this press release speak only as of the date of this press release. We assume no obligation to update our forward-looking statements whether as a result of new information, future events or otherwise, after the date of this press release.

Contact: Sylvia Wheeler SVP, Corporate Affairs 510 809 9264 Media Contact: Susan Lehner 510 809 2137 press@aduro.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Duolingo Faces Class Action: Key Investor Steps

Updated Category News Views 75

Navigating Turbulent Times with Duolingo Holy moly, the dumpster fire that is the Duolingo (NASDAQ:DUOL) legal saga just got hotter. If you snagged yourself some shares between May 2, 2025, and February 26, 2026, you'd better sit down and grab some antacids—because the nauseating roller coaster is far from over. Robbins LLP is rounding up the troops for a class action,...

Continue Reading
Scientific Games Joins NCPG’s 2026 Campaign Again

Updated Category News Views 142

Scientific Games Backs Responsible Gaming Again It's another year, and here's Scientific Games once more, guns blazing for a cause that's needed more than a few times over—responsible gambling. Those folks got their hearts in the right place, joining the National Council on Problem Gambling's 2026 Gift Responsibly campaign. Ninth time running, no less! It's like...

Continue Reading
Dr. Kumar Joins Florida Cancer Specialists Team

Updated Category News Views 141

Welcoming a New Oncology Specialist to Bradenton What does a small but mighty addition mean for cancer care in Bradenton, Florida? Well, it feels like a big win for the locals. Dr. Vinod Kumar is the latest name to join the ranks of the Florida Cancer Specialists & Research Institute (FCS) at the Bradenton Cancer Center. With years under his belt in medical oncology and...

Continue Reading
SANY's Bold AI Showdown at bauma CHINA 2026

Updated Category News Views 27

SANY's Future Vision: AI Agents and Robotic Machinery The construction machinery game is about to get a whole lot smarter, if SANY has anything to say about it. They're rolling out their biggest show ever at bauma CHINA 2026, and the headline act? A fresh breed of AI agents and robotic machinery that promises to revolutionize the industry. Marking its 40-year legacy, SANY...

Continue Reading
Saint Luis Rey Launches Exclusive Palatinos Vitola

Updated Category News Views 89

New Beginnings for the Saint Luis Rey Brand You think you've seen it all in the cigar world, but then comes a debut like this that lights a fire under the lush tradition of Cuba. Enter Saint Luis Rey's new Palatinos vitola, a blend wrapped in the mystique of exclusivity for La Casa del Habano and Habanos Specialists. Whether you're a seasoned connoisseur or just dipping...

Continue Reading
iHeartMedia Faces 65% Drop: Fraud Investigation Launched

Updated Category News Views 62

Trouble Tunes for iHeartMedia Investors Alright folks, here's the skinny on iHeartMedia, Inc. These days, it's like everyone's out for a piece of iHeart, and not in the way you'd wanna see—unless you're SBS Law, those shareholder rights hotshots diving into another pond of legal ripples. Seems a heap of head-scratching's going down on their version of transparency with...

Continue Reading
Midea's R290 Tech: Real Green Cooling Revolution?

Updated Category News Views 301

A Fresh Breeze in Sustainable Cooling In the middle of Kigali’s innovation oasis, Midea RAC stood out at MOP38, the 38th Meeting of the Parties to the Montreal Protocol, flexing its sustainable tech muscles. We're talking about their R290 air conditioning technology—a natural refrigerant with zero ozone footprint and a global warming potential of a mere three. This is...

Continue Reading
Cheyenne Real Estate: Neighborhood Nuances and Choices

Updated Category News Views 128

Unearthing the Hidden Dynamics of Cheyenne's Real Estate You've got this picturesque vision in your head of Cheyenne, Wyoming—a sprawling cowboy town with its wild winds and wide-open spaces. But if you think all those neighborhoods are cut from the same cloth, you've got another thing coming. The real estate scene here is just as varied as the prairies stretching out...

Continue Reading
TCL Unveils Black Friday Steals on Smart Devices

Updated Category News Views 104

TCL's Big Move This Holiday Season When was the last time you saw a deal that actually made you stop and check your wallet? Well, TCL is giving you a reason to dig deep this Black Friday and Cyber Monday. They're slashing prices across smartphones and tablets, trying to elbow their way into your shopping cart with discounts up to $150. Now that's the kind of aggressive...

Continue Reading
Elite Robots Expands Global Reach with Mobile Manipulators

Updated Category News Views 112

Robots Hitting the Road? Picture this: robots that aren't just bolted to a factory floor but roam the production lines like tireless workers on wheels. That's what Elite Robots is betting on with their shiny new ELITEMISSION mobile manipulators. Not Just Any Old Robot These bad boys combine a robotic arm with an autonomous mobile platform. Think of an octopus getting off...

Continue Reading
d -->

Top 5 Most Recently Viewed Articles

Market Fluctuations: NVIDIA, Micron, and SMCI Stocks Overview

Updated Category News Views 192

Market Update for NVIDIA, Micron, and SMCI Stocks Shares of NVIDIA Corp. (NASDAQ: NVDA), Super Micro Computer, Inc. (NASDAQ: SMCI), and Micron Technology, Inc. (NASDAQ: MU) have recently taken a noticeable dip. This drop has caught the eye of both investors and market analysts, leading to questions about what might be driving this trend. Current Hurdles in the...

Continue Reading
Hyundai Motor Shines at Cannes with Grand Prix and Gold Lions

Updated Category News Views 250

Hyundai Motor's Exceptional Recognition at Cannes Lions Hyundai Motor Company has made a remarkable impact at the prestigious Cannes Lions International Festival of Creativity. The company has achieved a Grand Prix award for its short film, 'Night Fishing,' a project that has been praised for its inventive storytelling and creative prowess. This Grand Prix marks a...

Continue Reading
EWTN's Expansion in Stockholm: A Strategic Faith Move

Updated Category News Views 54

A Bold Move into Northern Europe In what's shaping up to be a calculated leap of faith, the EWTN Global Catholic Network opened a new office in Stockholm, Sweden. Now, I don't usually get all warm and fuzzy over religious broadcasts, but this is less about spreading sermons and more about tapping into a growing market. Yeah, you heard me right—market. With the Catholic...

Continue Reading
Investors Urged to Act Now Amid 143% Cash Flow Decline

Updated Category News Views 135

Significant Concerns for StubHub Investors Investors in StubHub Holdings, Inc. (NYSE: STUB) are being urged to pay close attention as serious allegations surface concerning the company's recent financial disclosures. The prominent investor rights law firm Hagens Berman is reaching out to those investors who acquired shares during the company's Initial Public Offering...

Continue Reading
Walmart Leverages Automation to Rival Amazon's Dominance

Updated Category News Views 200

Walmart Ignites Technological Transformation Walmart Inc (NYSE: WMT) is not just a retailer; it's transforming into a technology powerhouse. While many might think of Amazon.com Inc (NASDAQ: AMZN) as the leader in tech-driven logistics, Walmart is ramping up its efforts. Recently, during a call with investors, the company's CFO highlighted a key milestone: "More than 50%...

Continue Reading